Creighton Model FertilityCare System
Creighton Model FertilityCare System (CrMS) is a form of Natural Family Planning that is used by women to monitor their reproductive health and fertility. It was developed by Dr. Thomas Hilgers at the Creighton University School of Medicine in the late 1970s.
Overview[edit]
The Creighton Model FertilityCare System is based on the observation and charting of biological markers, or "biomarkers", that are essential to a woman's health and fertility. These biomarkers tell the woman when she is naturally fertile and infertile, allowing her to use the system either to achieve or to avoid pregnancy.
Methodology[edit]
The CrMS involves the woman observing and recording certain physical signs, such as cervical mucus changes, that occur naturally throughout her menstrual cycle. These observations are then charted, which can help to identify patterns of fertility and infertility.
Effectiveness[edit]
Studies have shown that the Creighton Model FertilityCare System can be highly effective both for achieving and avoiding pregnancy. Its effectiveness for avoiding pregnancy is comparable to that of contraceptive pills, while its effectiveness for achieving pregnancy is significantly higher than that of other natural family planning methods.
Applications[edit]
In addition to its use for family planning, the Creighton Model FertilityCare System can also be used as a diagnostic tool. It can help to identify various reproductive and gynecological health issues, such as endometriosis, polycystic ovary syndrome, and infertility. It can also be used in conjunction with NaProTechnology, a new reproductive science that works cooperatively with the natural procreative cycle.
Training[edit]
Training in the Creighton Model FertilityCare System is available for both medical professionals and individuals. This training typically involves a combination of self-study, online learning, and in-person workshops.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian